Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An effort to improve the collection of patient-generated data: readability and understandability of patient-reported outcomes measures in a survivorship cohort.

Autor: Chiodi C; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France. camilakchiodi@gmail.com., Epstein J; Université de Lorraine, APEMAC, Nancy, France.; REFLIS, Paris, France.; French National Platform Quality of Life and Cancer, Paris, France., Arvis J; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France., Martin E; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France., Barbier A; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France., Di Meglio A; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France., Gillanders E; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France., Jacob G; Seintinelles, Paris, France., Menvielle G; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France., Everhard S; UNICANCER, Paris, France., Guillemin F; Université de Lorraine, APEMAC, Nancy, France.; REFLIS, Paris, France.; French National Platform Quality of Life and Cancer, Paris, France., Luis IV; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France.; Department for the Organization of Patient Pathways (DIOPP), Inserm Unit 981 Gustave Roussy, Villejuif, France., Franzoi MA; Cancer Survivorship Group, Inserm Unit 981 Gustave Roussy, Villejuif, France.

Publikováno v: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2024 May; Vol. 33 (5), pp. 1267-1274. Date of Electronic Publication: 2024 Mar 05.

Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.

Autor: Lambertini M; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U. O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Blondeaux E; U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Agostinetto E; Breast Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Hamy AS; Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France., Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Di Meglio A; Cancer Survivorship Program-Molecular Predicitors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Bernstein Molho R; Susanne Levy Gertner Oncogenetics Unit, Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center Affiliated to Tel Aviv University, Tel Hashomer, Israel., Hilbers F; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Carrasco E; Hereditary Cancer Genetics Unit, Medical Oncology Department, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology, Barcelona, Spain., Punie K; Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Bajpai J; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Ignatiadis M; Breast Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Moore HCF; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Toss A; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Center, Lyon, France., Peccatori FA; Gynecologic Oncology Department, European Institute of Oncology (IRCCS), Milan, Italy., Renaud T; Cancer Genetics Unit, Bergonie Institute, Bordeaux, France., Ferrari A; Hereditary Breast and Ovarian Cancer Unit and General Surgery 3-Senology, Surgical Department, Fondazione IRCCS Policlinico San Matteo, and University of Pavia, Pavia, Italy., Paluch-Shimon S; Breast Oncology Unit, Sharett Institute of Oncology, Hadassah University Hospital, and Faculty of Medicine, Hebrew University, Jerusalem, Israel., Fruscio R; UO Gynecology, Department of Medicine and Surgery, University of Milan-Bicocca, IRCCS San Gerardo dei Tintori, Monza, Italy., Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Wong SM; Stroll Cancer Prevention Centre, Jewish General Hospital, and McGill University Medical School, Montreal, Quebec, Canada., Vernieri C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; IFOM ETS, AIRC Institute of Molecular Oncology, Milan, Italy., Ruddy KJ; Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota., Dieci MV; Dipartimento di Scienze Chirurgiche, Oncologiche, e Gastroenterologiche, Università di Padova, Padova, Italy.; Oncologia 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Matikas A; Department of Oncology/Pathology, Karolinska Institute, and Breast Center, Karolinska University Hospital, Stockholm, Sweden., Rozenblit M; Department of Medical Oncology, Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut., Villarreal-Garza C; Breast Cancer Center, Hospital Zambrano Hellion-TecSalud, Tecnologico de Monterrey, Monterrey, Mexico., De Marchis L; Department of Radiological, Oncological, and Pathological Sciences, Sapienza University of Rome, Rome, Italy.; Division of Oncology, Department of Hematology, Oncology, and Dermatology, Umberto 1 University Hospital, Rome, Italy., Del Mastro L; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U. O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Avano (CRO) IRCCS, Aviano, Italy.; Department of Medicine, University of Udine, Udine, Italy., Del Pilar Estevez-Diz M; Department of Radiology and Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Rodriguez-Wallberg KA; Department of Oncology-Pathology, Laboratory of Translational Fertility Preservation, Karolinska Institute, Stockholm, Sweden.; Department of Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden., Mrinakova B; First Department of Oncology, Comenius University and St Elisabeth Cancer Institute, Bratislava, Slovakia., Meister S; Department of Obstetrics and Gynecology, Ludwig Maximilian University (LMU) Hospital, LMU Munich, Germany., Livraghi L; Department of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Italy., Clatot F; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France., Yerushalmi R; Department of Medical Oncology, Davidoff Center, Rabin Medical Center, Petah Tikva, Tel Aviv University, Tel Aviv, Israel., De Angelis C; Department of Medical Oncology, University of Naples Federico II, Napoli, Italy., Sánchez-Bayona R; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Meattini I; Department of Experimental and Clinical Biomedical Sciences M. Serio, University of Florence, and Radiation Oncology Unit, Oncology Department, Florence University Hospital, Florence, Italy., Cichowska-Cwalinska N; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.; Early Phase Clinical Trials Centre, Medical University of Gdańsk, Gdańsk, Poland., Berlière M; Department of Medical Oncology and Breast Surgery, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Belgium., Salama M; Oncofertility Consortium and Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University, East Lansing., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy., Sonnenblick A; Oncology Division, Tel Aviv Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Chiodi C; Cancer Survivorship Program-Molecular Predicitors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Lee YJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Maria C; Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France., Azim HA Jr; Breast Cancer Center, Hospital Zambrano Hellion-TecSalud, Tecnologico de Monterrey, Monterrey, Mexico.; Cairo Oncology Center, Cairo, Egypt., Boni L; U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publikováno v: JAMA [JAMA] 2024 Jan 02; Vol. 331 (1), pp. 49-59.

Implementing a PROACTive Care Pathway to Empower and Support Survivors of Breast Cancer.

Autor: Franzoi MA; Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France., Degousée L; Breast Oncology Unit, Gustave Roussy, Villejuif, France., Martin E; Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.; CNRS-UAR3683 MSH Paris-Saclay, Gif sur Yvette, France., Semedo PM; Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal., Aupomerol M; Breast Oncology Unit, Gustave Roussy, Villejuif, France., Soldato D; Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France., Di Meglio A; Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France., Chiodi C; Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France., Barbier A; Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France., Chaouachi H; Supportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France., Renvoisé N; Supportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France., Boinon D; Supportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France., Fasse L; Supportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France., Ribeiro J; Breast Oncology Unit, Gustave Roussy, Villejuif, France., Le-Provost JB; Supportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France., Arvis J; Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France., Lazorthes C; Resilience Care, Paris, France., di Palma M; Supportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France., de Jesus A; Patient Committee, Gustave Roussy, Villejuif, France., Raynard B; Supportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France., Pagès A; Biostatistics and Epidemiology Department, Gustave Roussy, Villejuif, France., Delaloge S; Breast Oncology Unit, Gustave Roussy, Villejuif, France., Pistilli B; Breast Oncology Unit, Gustave Roussy, Villejuif, France., Scotté F; Supportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France., Vaz-Luis I; Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.; Breast Oncology Unit, Gustave Roussy, Villejuif, France.; Supportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2023 Jun; Vol. 19 (6), pp. 353-361.

A dual-omics approach for profiling plant responses to biostimulant applications under controlled and field conditions.

Autor: Baghdadi A; Department of Agricultural and Food Sciences, University of Bologna, Bologna, Italy., Della Lucia MC; Department of Agronomy, Food, Natural Resources, Animals and Environment, University of Padova, Legnaro, Italy., Borella M; Department of Agronomy, Food, Natural Resources, Animals and Environment, University of Padova, Legnaro, Italy., Bertoldo G; Department of Agronomy, Food, Natural Resources, Animals and Environment, University of Padova, Legnaro, Italy., Ravi S; Department of Agronomy, Food, Natural Resources, Animals and Environment, University of Padova, Legnaro, Italy., Zegada-Lizarazu W; Department of Agricultural and Food Sciences, University of Bologna, Bologna, Italy., Chiodi C; Crop Production and Biostimulation Laboratory, Brussels Bioengineering School, Université libre de Bruxelles, Brussels, Belgium., Pagani E; Department of Agricultural and Food Sciences, University of Bologna, Bologna, Italy., Hermans C; Crop Production and Biostimulation Laboratory, Brussels Bioengineering School, Université libre de Bruxelles, Brussels, Belgium., Stevanato P; Department of Agronomy, Food, Natural Resources, Animals and Environment, University of Padova, Legnaro, Italy., Nardi S; Department of Agronomy, Food, Natural Resources, Animals and Environment, University of Padova, Legnaro, Italy., Monti A; Department of Agricultural and Food Sciences, University of Bologna, Bologna, Italy., Mangione F; Sipcam Italia S.p.A. belonging together with Sofbey SA to the Sipcam Oxon S.p.A. Group, Pero, MI, Italy.

Publikováno v: Frontiers in plant science [Front Plant Sci] 2022 Sep 26; Vol. 13, pp. 983772. Date of Electronic Publication: 2022 Sep 26 (Print Publication: 2022).